Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
On-the-road driving performance after use of the antihistamines mequitazine and l-mequitazine, alone and with alcohol.
van der Sluiszen NN, Vermeeren A, Jongen S, Theunissen EL, van Oers AC, Van Leeuwen CJ, Maret A, Desforges C, Delarue A, Ramaekers JG. van der Sluiszen NN, et al. Among authors: van leeuwen cj. Psychopharmacology (Berl). 2016 Sep;233(18):3461-9. doi: 10.1007/s00213-016-4386-7. Epub 2016 Aug 4. Psychopharmacology (Berl). 2016. PMID: 27488192 Free PMC article. Clinical Trial.
Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.
Bosker WM, Kuypers KP, Theunissen EL, Surinx A, Blankespoor RJ, Skopp G, Jeffery WK, Walls HC, van Leeuwen CJ, Ramaekers JG. Bosker WM, et al. Among authors: van leeuwen cj. Addiction. 2012 Oct;107(10):1837-44. doi: 10.1111/j.1360-0443.2012.03928.x. Epub 2012 Jul 12. Addiction. 2012. PMID: 22553980 Clinical Trial.
On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers.
Vermeeren A, Sun H, Vuurman EF, Jongen S, Van Leeuwen CJ, Van Oers AC, Palcza J, Li X, Laethem T, Heirman I, Bautmans A, Troyer MD, Wrishko R, McCrea J. Vermeeren A, et al. Among authors: van leeuwen cj. Sleep. 2015 Nov 1;38(11):1803-13. doi: 10.5665/sleep.5168. Sleep. 2015. PMID: 26039969 Free PMC article. Clinical Trial.
Erratum to: On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers.
Vermeeren A, Jongen S, Murphy P, Moline M, Filippov G, Pinner K, Perdomo C, Landry I, Majid O, Van Oers ACM, Van Leeuwen CJ, Ramaekers JG, Vuurman EFPM. Vermeeren A, et al. Among authors: van leeuwen cj. Sleep. 2020 Jul 13;43(7):zsaa068. doi: 10.1093/sleep/zsaa068. Sleep. 2020. PMID: 32396197 Free PMC article. No abstract available.
A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression.
Reckweg JT, van Leeuwen CJ, Henquet C, van Amelsvoort T, Theunissen EL, Mason NL, Paci R, Terwey TH, Ramaekers JG. Reckweg JT, et al. Among authors: van leeuwen cj. Front Psychiatry. 2023 Jun 20;14:1133414. doi: 10.3389/fpsyt.2023.1133414. eCollection 2023. Front Psychiatry. 2023. PMID: 37409159 Free PMC article.
37 results